Study of Progression of Community Acquired Pneumonia in the Hospital in Patients With More Severe Preexisting Diseases and Immunosuppression
Key facts
- Who runs it
- Pneumonia Research Network on Genetic Resistance and Susceptibility for the Evolution of Severe Seps
- Where
- Germany10 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 300 people, planned
- Started
- 28 Feb 2022
- Expected to end
- 28 Feb 2028
- Type of study
- Observational
- Record updated
- 13 March 2024
Who can take part
- Age
- 18 years to 99 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- Hospitalization with community acquired pneumonia (CAP) confirmed by pulmonary infiltrate in chest imaging
- Valid informed consent form
- Working diagnosis of CAP by enrolling physician
- No hospitalization for any reason within 28 days prior to hospitalization for the current episode of CAP
- At least 2 out of the five following clinical symptoms:; Fever; Cough; Purulent sputum; Shortness of breath or need for respiratory support; Crackling or rales on auscultation, dullness to percussion, or bronchial breathing
- At least 1 of the following criteria; Known HIV infection or AIDS; Anti-tumor treatment within the past six months; Therapy with corticosteroids ≥ 20mg for ≥ 14 days before enrollment; Non-steroidal immunosuppressive therapy within the past six months; Cytostatic therapy within the past six months; Radiation therapy within the past six months; Bone marrow transplant received; Respiratory support at home via tracheostoma; Cystic fibrosis; Heart failure: New York Heart Association (NYHA) Stadium IV or HFrEF (defined as left ventricular ejection fraction <40%); Decompensated liver disease (Child-Pugh class C); Diabetes mellitus with HbA1c ≥ 8,5 %; End-stage renal disease requiring dialysis; Pulmonary hypertension (all classes) with mPAP > 20 mmHg (right heart catheter)
Who cannot take part
- Active tuberculosis
- Acute lung injury or acute respiratory distress syndrome for extrapulmonary reasons
- Participation in this study at an earlier time
- More than 48 hours in the hospital before enrollment (for patients directly to intensive care: more than 7 days)
- Pregnancy
- Breastfeeding
- Massive aspiration
- Sepsis with extrapulmonary focus
- Acute pulmonary embolism
The main criteria, as questions
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 99 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Pneumonia is a common infectious disease of the lung, often requiring treatment in the hospital. Clinical scoring systems are available, identifying patients not requiring hospitalization. However, the course of disease of patients in the hospital remains hard to predict. While most patients will recover quickly, some will, despite appropriate treatment, develop a severe course leading to sepsis and systemic responses resulting in organ dysfunction. The PROGRESS consortium aims to identify clinical, genetic, and other molecular markers and combinations there of predicting a severe course of pneumonia in the hospital. Such predictors will, for instance, support decisions on earlier transfer of patients to intensive care and thus improving outcome. PROGRESS-COMORB aims to extend findings from the previous PROGRESS study to patients with more severe preexisting conditions and immunosuppression.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Study of Progression of Hospitalized Community Acquired Pneumonia - Genetic Resistance and Susceptibility for the Evolution of Severe Sepsis in Patients With More Severe Preexisting Diseases and Immunosuppression to Complement the PROGRESS CAP Cohort
- Criteria questions
- Built from NCT05688774, who can take part
- Record updated
- 13 March 2024